| Dr Beverly Floresca, PSYD | |
|
621 E Campbell Ave, Suite 7, Campbell, CA 95008-2139 | |
| (408) 540-6700 | |
| Not Available |
| Full Name | Dr Beverly Floresca |
|---|---|
| Gender | Female |
| Speciality | Psychologist - Clinical |
| Location | 621 E Campbell Ave, Campbell, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1376733816 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TC0700X | Psychologist - Clinical | PSY 21566 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Beverly Floresca, PSYD 4737 Natalie Ave, Fremont, CA 94538-2516 Ph: () - | Dr Beverly Floresca, PSYD 621 E Campbell Ave, Suite 7, Campbell, CA 95008-2139 Ph: (408) 540-6700 |
News Archive
Rural emergency departments often lack the medical specialists who staff larger, urban hospitals. Yet rural patients have the same conditions-and need the same prompt care-that people in cities do.
The U.S. Food and Drug Administration today approved Vonvendi, von Willebrand factor (Recombinant), for use in adults 18 years of age and older who have von Willebrand disease (VWD). Vonvendi is the first FDA-approved recombinant von Willebrand factor, and is approved for the on-demand (as needed) treatment and control of bleeding episodes in adults diagnosed with VWD.
The Guided Therapeutics, Inc. LightTouch™ Cervical Scanner increased detection of significant disease over Pap tests in women seen in a busy private practice setting, according to results of a U.S. Food and Drug Administration pivotal clinical trial presented at the American Society for Colposcopy and Cervical Pathology biennial meeting.
The National Institutes of Health (NIH) has awarded researchers at Albert Einstein College of Medicine at Yeshiva University a five-year, $5.9 million grant to develop a new vaccine against tuberculosis (TB), including the toughest-to-treat forms of the disease known as multi drug-resistant and extensively drug-resistant. The grant will build on a new approach to TB vaccine design that is based on genetically altered Mycobacterium smegmatis, which is closely related to the bacterial species (Mycobacterium tuberculosis) that causes TB in humans.
› Verified 9 days ago
Dr. Roger Per-erik Karlsson, PH.D., ABPP Psychologist Medicare: Not Enrolled in Medicare Practice Location: 51 East Campbell Avenue, Ste 170, Campbell, CA 95008 Phone: 510-847-5592 | |
Karen Leslie Brinkman, LMFT Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1999 S Bascom Ave Ste 700, Campbell, CA 95008 Phone: 408-466-5774 | |
Dr. Colleen Anne Johnson, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 15 Maravilla Ct, Campbell, CA 95008 Phone: 408-781-8434 | |
Dr. Terri Ladonna Thompson, PSY.D. Psychologist Medicare: Medicare Enrolled Practice Location: 900 E Hamilton Ave, Suite 100, Campbell, CA 95008 Phone: 408-802-6391 Fax: 408-879-7205 | |
Dr. Rebecca Caldwell, PSYD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 2542 S Bascom Ave Ste 100, Campbell, CA 95008 Phone: 800-913-2615 | |
Dr. Christopher Scott Polizzi, PSY.D. Psychologist Medicare: Accepting Medicare Assignments Practice Location: 901 Campisi Way, Ste 150, Campbell, CA 95008 Phone: 408-827-1942 Fax: 408-628-0042 | |
Dr. David Frederick Dahl, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 2542 S Bascom Ave, Ste 265, Campbell, CA 95008 Phone: 408-793-0313 Fax: 408-796-7592 |